Securities Class Actions Down But Not Out After Suboxone
By Joanne Faulkner ( January 24, 2025, 7:15 PM GMT) -- The Court of Appeal's refusal to allow investors in Reckitt and Indivior to bring a novel group claim over the marketing of an opioid addiction treatment marks a further setback for shareholders looking to hold listed companies liable for plunges in share prices....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.